Artificial Intelligence in Medication Management for Alzheimer's Patients in China

Open Access
Article
Conference Proceedings
Authors: Xinyue ZhangRafiq ElmansyJingyang Liu
Abstract

This study provides a comprehensive overview of artificial intelligence (AI) in China's pharmaceutical Alzheimer's management by examining past research. The focus is on critical factors that affect medicine adherence and major AI breakthroughs and trends. A systematic analysis examines how artificial intelligence can monitor medication adherence, give reminders, and discover drug interactions. These apps may improve patient adherence, therapeutic efficacy, and quality of life. However, literature gaps emphasise the need for more research. In conclusion, future projects should address these gaps to serve patients better, improve treatment outcomes, and navigate ethical and policy issues, advancing Alzheimer's drug management.

Keywords: Alzheimer's, Artificial Intelligence, Medication Management, Medication Adherence.

DOI: 10.54941/ahfe1004834

Cite this paper
Downloads
564
Visits
1331
Download PDF

More from this volume

Challenges and Uncertainties in Violence Risk Assessment: A Critical Examination of Practice and National Guidelines in Norway's Specialist Mental Health ServicesExploring Self-Medication Practices Among Undergraduate University Students: A Qualitative Descriptive Study
View all articles in Healthcare and Medical Devices